Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-106453

MAGELLAN HEALTH INC · MGLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 2:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)F2,F1$64.87Mar 3, 2016A21,920A—Mar 3, 2026Common Stock21,92021,920D
Performance-Based Restricted Stock UnitsF2,F3,F4$0.00Mar 3, 2016A5,123AMar 3, 2019—Common Stock5,1235,123D

Explanation of responses